NCT06022757 Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19) Status RECRUITING Phase PHASE1/PHASE2
NCT05965856 A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors Status RECRUITING Phase PHASE2
NCT05923190 Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05912205 Disitamab Vedotin Combined With Radiotherapy for Bladder Preservation Status NOT_YET_RECRUITING Phase PHASE2
NCT05911295 Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05894447 Naptumomab Estafenatox in Combination With Pembrolizumab Preceded by Obinutuzumab in Patients With Urothelial Cancers Status WITHDRAWN Phase PHASE1
NCT05893316 UroCAD for Hematuria Evaluation--A Prospective, Multi-center Study Status UNKNOWN Phase N/A
NCT05889195 Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria Status RECRUITING Phase N/A
NCT05874921 uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto Status RECRUITING Phase N/A
NCT05868265 A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract Status RECRUITING Phase PHASE2
NCT05867303 A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05861947 A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies Status TERMINATED Phase PHASE1
NCT05823246 Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma Status UNKNOWN Phase PHASE2
NCT05775874 A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC Status RECRUITING Phase PHASE2
NCT05768347 Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05723991 Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma Status UNKNOWN Phase PHASE4
NCT05714553 NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours Status TERMINATED Phase PHASE1/PHASE2